nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2A6—Rifampicin—leprosy	0.143	0.184	CbGbCtD
Eletriptan—PTGS1—Thalidomide—leprosy	0.126	0.162	CbGbCtD
Eletriptan—PTGS1—Dapsone—leprosy	0.101	0.129	CbGbCtD
Eletriptan—CYP2C19—Thalidomide—leprosy	0.0611	0.0784	CbGbCtD
Eletriptan—CYP2C19—Rifampicin—leprosy	0.0592	0.0759	CbGbCtD
Eletriptan—CYP2C9—Thalidomide—leprosy	0.0508	0.0652	CbGbCtD
Eletriptan—CYP2C9—Rifampicin—leprosy	0.0492	0.0631	CbGbCtD
Eletriptan—CYP2C19—Dapsone—leprosy	0.0489	0.0627	CbGbCtD
Eletriptan—ABCB1—Rifampicin—leprosy	0.0478	0.0612	CbGbCtD
Eletriptan—CYP2C9—Dapsone—leprosy	0.0406	0.0521	CbGbCtD
Eletriptan—CYP3A4—Rifampicin—leprosy	0.0286	0.0367	CbGbCtD
Eletriptan—CYP3A4—Dapsone—leprosy	0.0236	0.0303	CbGbCtD
Eletriptan—HTR1F—trigeminal nerve—leprosy	0.0208	0.253	CbGeAlD
Eletriptan—HTR1B—trigeminal nerve—leprosy	0.00853	0.104	CbGeAlD
Eletriptan—HTR1D—trigeminal nerve—leprosy	0.00826	0.1	CbGeAlD
Eletriptan—HTR1B—cranial nerve—leprosy	0.00608	0.0739	CbGeAlD
Eletriptan—HTR1D—cranial nerve—leprosy	0.00589	0.0715	CbGeAlD
Eletriptan—HTR7—cranial nerve—leprosy	0.00469	0.057	CbGeAlD
Eletriptan—Lacrimal structural disorder—Thalidomide—leprosy	0.00391	0.0283	CcSEcCtD
Eletriptan—HTR7—peripheral nervous system—leprosy	0.00308	0.0374	CbGeAlD
Eletriptan—Dementia—Thalidomide—leprosy	0.0028	0.0203	CcSEcCtD
Eletriptan—Lacrimal disorder—Thalidomide—leprosy	0.00257	0.0186	CcSEcCtD
Eletriptan—Hernia—Thalidomide—leprosy	0.00245	0.0178	CcSEcCtD
Eletriptan—HTR1B—blood vessel—leprosy	0.00245	0.0297	CbGeAlD
Eletriptan—HTR7—nerve—leprosy	0.0024	0.0292	CbGeAlD
Eletriptan—HTR1D—blood vessel—leprosy	0.00237	0.0288	CbGeAlD
Eletriptan—Peripheral vascular disorder—Thalidomide—leprosy	0.00234	0.017	CcSEcCtD
Eletriptan—Enlargement abdomen—Thalidomide—leprosy	0.00191	0.0138	CcSEcCtD
Eletriptan—HTR7—blood vessel—leprosy	0.00189	0.0229	CbGeAlD
Eletriptan—Myasthenia—Thalidomide—leprosy	0.00183	0.0132	CcSEcCtD
Eletriptan—Psoriasis—Thalidomide—leprosy	0.00183	0.0132	CcSEcCtD
Eletriptan—Tooth disorder—Thalidomide—leprosy	0.00177	0.0128	CcSEcCtD
Eletriptan—HTR1F—nervous system—leprosy	0.00171	0.0208	CbGeAlD
Eletriptan—Menstrual disorder—Thalidomide—leprosy	0.00168	0.0122	CcSEcCtD
Eletriptan—Burning sensation—Thalidomide—leprosy	0.00165	0.012	CcSEcCtD
Eletriptan—Cyanosis—Thalidomide—leprosy	0.00162	0.0118	CcSEcCtD
Eletriptan—Stupor—Thalidomide—leprosy	0.00154	0.0112	CcSEcCtD
Eletriptan—HTR1E—nervous system—leprosy	0.00148	0.018	CbGeAlD
Eletriptan—Hyperaesthesia—Thalidomide—leprosy	0.00146	0.0106	CcSEcCtD
Eletriptan—Muscular weakness—Dapsone—leprosy	0.00144	0.0104	CcSEcCtD
Eletriptan—Myocardial ischaemia—Thalidomide—leprosy	0.00143	0.0104	CcSEcCtD
Eletriptan—Tingling sensation—Thalidomide—leprosy	0.00143	0.0104	CcSEcCtD
Eletriptan—Influenza—Dapsone—leprosy	0.00141	0.0102	CcSEcCtD
Eletriptan—Numbness—Thalidomide—leprosy	0.00138	0.01	CcSEcCtD
Eletriptan—Sensory loss—Thalidomide—leprosy	0.00133	0.00961	CcSEcCtD
Eletriptan—PTGS1—blood vessel—leprosy	0.0013	0.0158	CbGeAlD
Eletriptan—Accidental injury—Thalidomide—leprosy	0.0013	0.00941	CcSEcCtD
Eletriptan—Viral infection—Thalidomide—leprosy	0.00127	0.00922	CcSEcCtD
Eletriptan—Skin discolouration—Thalidomide—leprosy	0.00127	0.00922	CcSEcCtD
Eletriptan—Arthropathy—Thalidomide—leprosy	0.00126	0.00916	CcSEcCtD
Eletriptan—Hyperbilirubinaemia—Thalidomide—leprosy	0.00126	0.00916	CcSEcCtD
Eletriptan—HTR1D—eye—leprosy	0.00126	0.0153	CbGeAlD
Eletriptan—Thinking abnormal—Thalidomide—leprosy	0.00125	0.00909	CcSEcCtD
Eletriptan—Neuropathy peripheral—Dapsone—leprosy	0.00123	0.00892	CcSEcCtD
Eletriptan—Bone pain—Thalidomide—leprosy	0.0012	0.00869	CcSEcCtD
Eletriptan—Atrioventricular block—Thalidomide—leprosy	0.00118	0.00858	CcSEcCtD
Eletriptan—Sinusitis—Dapsone—leprosy	0.00118	0.00854	CcSEcCtD
Eletriptan—Gait disturbance—Thalidomide—leprosy	0.00118	0.00853	CcSEcCtD
Eletriptan—Coordination abnormal—Thalidomide—leprosy	0.00117	0.00848	CcSEcCtD
Eletriptan—Phosphatase alkaline increased—Thalidomide—leprosy	0.00115	0.00833	CcSEcCtD
Eletriptan—Eructation—Thalidomide—leprosy	0.00113	0.00818	CcSEcCtD
Eletriptan—Pharyngitis—Dapsone—leprosy	0.00112	0.00811	CcSEcCtD
Eletriptan—Depressed level of consciousness—Thalidomide—leprosy	0.00111	0.00804	CcSEcCtD
Eletriptan—Candida infection—Thalidomide—leprosy	0.0011	0.00795	CcSEcCtD
Eletriptan—Neuropathy—Thalidomide—leprosy	0.00108	0.00782	CcSEcCtD
Eletriptan—Dry eye—Thalidomide—leprosy	0.00106	0.00769	CcSEcCtD
Eletriptan—Tinnitus—Dapsone—leprosy	0.00105	0.00761	CcSEcCtD
Eletriptan—Oesophagitis—Thalidomide—leprosy	0.00105	0.00761	CcSEcCtD
Eletriptan—Rash maculo-papular—Thalidomide—leprosy	0.00104	0.00757	CcSEcCtD
Eletriptan—HTR2B—skin of body—leprosy	0.00102	0.0124	CbGeAlD
Eletriptan—Hypertonia—Thalidomide—leprosy	0.00101	0.0073	CcSEcCtD
Eletriptan—Hyperkinesia—Thalidomide—leprosy	0.001	0.00726	CcSEcCtD
Eletriptan—Mental disability—Thalidomide—leprosy	0.000996	0.00722	CcSEcCtD
Eletriptan—Euphoric mood—Thalidomide—leprosy	0.000986	0.00715	CcSEcCtD
Eletriptan—Lymphadenopathy—Thalidomide—leprosy	0.000977	0.00708	CcSEcCtD
Eletriptan—Thrombophlebitis—Thalidomide—leprosy	0.000963	0.00698	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000958	0.00695	CcSEcCtD
Eletriptan—Vascular purpura—Thalidomide—leprosy	0.000932	0.00676	CcSEcCtD
Eletriptan—Eczema—Thalidomide—leprosy	0.000927	0.00672	CcSEcCtD
Eletriptan—Eye pain—Thalidomide—leprosy	0.000923	0.00669	CcSEcCtD
Eletriptan—Injury—Thalidomide—leprosy	0.000907	0.00657	CcSEcCtD
Eletriptan—Amnesia—Thalidomide—leprosy	0.000887	0.00643	CcSEcCtD
Eletriptan—Increased appetite—Thalidomide—leprosy	0.000887	0.00643	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Thalidomide—leprosy	0.000883	0.0064	CcSEcCtD
Eletriptan—Vertigo—Dapsone—leprosy	0.000881	0.00639	CcSEcCtD
Eletriptan—Atrial fibrillation—Thalidomide—leprosy	0.000879	0.00638	CcSEcCtD
Eletriptan—Purpura—Thalidomide—leprosy	0.000865	0.00627	CcSEcCtD
Eletriptan—Arthritis—Thalidomide—leprosy	0.000857	0.00622	CcSEcCtD
Eletriptan—Cough—Dapsone—leprosy	0.000856	0.0062	CcSEcCtD
Eletriptan—Diplopia—Thalidomide—leprosy	0.000833	0.00604	CcSEcCtD
Eletriptan—Osteoarthritis—Thalidomide—leprosy	0.000833	0.00604	CcSEcCtD
Eletriptan—Migraine—Thalidomide—leprosy	0.00082	0.00595	CcSEcCtD
Eletriptan—Affect lability—Thalidomide—leprosy	0.00082	0.00595	CcSEcCtD
Eletriptan—Face oedema—Thalidomide—leprosy	0.000805	0.00583	CcSEcCtD
Eletriptan—Mood swings—Thalidomide—leprosy	0.000789	0.00573	CcSEcCtD
Eletriptan—Ataxia—Thalidomide—leprosy	0.000784	0.00568	CcSEcCtD
Eletriptan—Tachycardia—Dapsone—leprosy	0.000781	0.00566	CcSEcCtD
Eletriptan—HTR2B—tendon—leprosy	0.000777	0.00944	CbGeAlD
Eletriptan—ABCB1—blood vessel—leprosy	0.000771	0.00937	CbGeAlD
Eletriptan—Liver function test abnormal—Thalidomide—leprosy	0.000769	0.00558	CcSEcCtD
Eletriptan—Dry skin—Thalidomide—leprosy	0.000764	0.00554	CcSEcCtD
Eletriptan—Cramp muscle—Thalidomide—leprosy	0.00075	0.00544	CcSEcCtD
Eletriptan—Muscular weakness—Thalidomide—leprosy	0.000735	0.00533	CcSEcCtD
Eletriptan—Abdominal distension—Thalidomide—leprosy	0.000725	0.00526	CcSEcCtD
Eletriptan—Insomnia—Dapsone—leprosy	0.000724	0.00525	CcSEcCtD
Eletriptan—Dysphagia—Thalidomide—leprosy	0.00072	0.00522	CcSEcCtD
Eletriptan—Influenza—Thalidomide—leprosy	0.00072	0.00522	CcSEcCtD
Eletriptan—Angina pectoris—Thalidomide—leprosy	0.000702	0.00509	CcSEcCtD
Eletriptan—HTR1B—nervous system—leprosy	0.000701	0.00851	CbGeAlD
Eletriptan—Bronchitis—Thalidomide—leprosy	0.000693	0.00502	CcSEcCtD
Eletriptan—HTR1D—nervous system—leprosy	0.000679	0.00824	CbGeAlD
Eletriptan—Pollakiuria—Thalidomide—leprosy	0.000665	0.00483	CcSEcCtD
Eletriptan—HTR7—tendon—leprosy	0.000665	0.00808	CbGeAlD
Eletriptan—Erectile dysfunction—Thalidomide—leprosy	0.000663	0.00481	CcSEcCtD
Eletriptan—Weight increased—Thalidomide—leprosy	0.000656	0.00475	CcSEcCtD
Eletriptan—Gastrointestinal pain—Dapsone—leprosy	0.000654	0.00474	CcSEcCtD
Eletriptan—Weight decreased—Thalidomide—leprosy	0.000652	0.00473	CcSEcCtD
Eletriptan—Hyperglycaemia—Thalidomide—leprosy	0.00065	0.00471	CcSEcCtD
Eletriptan—Drowsiness—Thalidomide—leprosy	0.000642	0.00466	CcSEcCtD
Eletriptan—Acute coronary syndrome—Thalidomide—leprosy	0.000633	0.00459	CcSEcCtD
Eletriptan—Abdominal pain—Dapsone—leprosy	0.000633	0.00459	CcSEcCtD
Eletriptan—Body temperature increased—Dapsone—leprosy	0.000633	0.00459	CcSEcCtD
Eletriptan—HTR2B—nervous system—leprosy	0.000631	0.00767	CbGeAlD
Eletriptan—Myocardial infarction—Thalidomide—leprosy	0.00063	0.00457	CcSEcCtD
Eletriptan—Neuropathy peripheral—Thalidomide—leprosy	0.00063	0.00457	CcSEcCtD
Eletriptan—Stomatitis—Thalidomide—leprosy	0.000626	0.00454	CcSEcCtD
Eletriptan—Conjunctivitis—Thalidomide—leprosy	0.000624	0.00453	CcSEcCtD
Eletriptan—Sweating—Thalidomide—leprosy	0.000616	0.00446	CcSEcCtD
Eletriptan—Epistaxis—Thalidomide—leprosy	0.000606	0.00439	CcSEcCtD
Eletriptan—PTGS1—skin of body—leprosy	0.000604	0.00734	CbGeAlD
Eletriptan—Sinusitis—Thalidomide—leprosy	0.000603	0.00437	CcSEcCtD
Eletriptan—Bradycardia—Thalidomide—leprosy	0.000587	0.00426	CcSEcCtD
Eletriptan—Rhinitis—Thalidomide—leprosy	0.000578	0.00419	CcSEcCtD
Eletriptan—Hypoaesthesia—Thalidomide—leprosy	0.000574	0.00416	CcSEcCtD
Eletriptan—Pharyngitis—Thalidomide—leprosy	0.000572	0.00415	CcSEcCtD
Eletriptan—Urinary tract disorder—Thalidomide—leprosy	0.000569	0.00413	CcSEcCtD
Eletriptan—Oedema peripheral—Thalidomide—leprosy	0.000568	0.00412	CcSEcCtD
Eletriptan—HTR1A—nervous system—leprosy	0.000566	0.00687	CbGeAlD
Eletriptan—Urethral disorder—Thalidomide—leprosy	0.000565	0.0041	CcSEcCtD
Eletriptan—Visual impairment—Thalidomide—leprosy	0.000556	0.00403	CcSEcCtD
Eletriptan—HTR7—testis—leprosy	0.000551	0.00669	CbGeAlD
Eletriptan—HTR7—nervous system—leprosy	0.000541	0.00657	CbGeAlD
Eletriptan—Tinnitus—Thalidomide—leprosy	0.000538	0.0039	CcSEcCtD
Eletriptan—Immune system disorder—Thalidomide—leprosy	0.000521	0.00378	CcSEcCtD
Eletriptan—Chills—Thalidomide—leprosy	0.000517	0.00375	CcSEcCtD
Eletriptan—Arrhythmia—Thalidomide—leprosy	0.000515	0.00373	CcSEcCtD
Eletriptan—Alopecia—Thalidomide—leprosy	0.000509	0.00369	CcSEcCtD
Eletriptan—Vomiting—Dapsone—leprosy	0.000509	0.00369	CcSEcCtD
Eletriptan—Headache—Dapsone—leprosy	0.000501	0.00363	CcSEcCtD
Eletriptan—Flatulence—Thalidomide—leprosy	0.000495	0.00359	CcSEcCtD
Eletriptan—Tension—Thalidomide—leprosy	0.000492	0.00357	CcSEcCtD
Eletriptan—Dysgeusia—Thalidomide—leprosy	0.000491	0.00356	CcSEcCtD
Eletriptan—Nervousness—Thalidomide—leprosy	0.000487	0.00353	CcSEcCtD
Eletriptan—Back pain—Thalidomide—leprosy	0.000485	0.00352	CcSEcCtD
Eletriptan—Muscle spasms—Thalidomide—leprosy	0.000483	0.0035	CcSEcCtD
Eletriptan—Nausea—Dapsone—leprosy	0.000475	0.00345	CcSEcCtD
Eletriptan—Tremor—Thalidomide—leprosy	0.00047	0.00341	CcSEcCtD
Eletriptan—Ill-defined disorder—Thalidomide—leprosy	0.000466	0.00338	CcSEcCtD
Eletriptan—Anaemia—Thalidomide—leprosy	0.000464	0.00336	CcSEcCtD
Eletriptan—Agitation—Thalidomide—leprosy	0.000461	0.00334	CcSEcCtD
Eletriptan—PTGS1—tendon—leprosy	0.00046	0.00558	CbGeAlD
Eletriptan—Angioedema—Thalidomide—leprosy	0.000459	0.00333	CcSEcCtD
Eletriptan—Malaise—Thalidomide—leprosy	0.000453	0.00328	CcSEcCtD
Eletriptan—Vertigo—Thalidomide—leprosy	0.000451	0.00327	CcSEcCtD
Eletriptan—Syncope—Thalidomide—leprosy	0.00045	0.00326	CcSEcCtD
Eletriptan—Leukopenia—Thalidomide—leprosy	0.000449	0.00326	CcSEcCtD
Eletriptan—Palpitations—Thalidomide—leprosy	0.000444	0.00322	CcSEcCtD
Eletriptan—Loss of consciousness—Thalidomide—leprosy	0.000441	0.0032	CcSEcCtD
Eletriptan—Cough—Thalidomide—leprosy	0.000438	0.00318	CcSEcCtD
Eletriptan—Convulsion—Thalidomide—leprosy	0.000435	0.00315	CcSEcCtD
Eletriptan—Hypertension—Thalidomide—leprosy	0.000433	0.00314	CcSEcCtD
Eletriptan—Myalgia—Thalidomide—leprosy	0.000427	0.0031	CcSEcCtD
Eletriptan—Arthralgia—Thalidomide—leprosy	0.000427	0.0031	CcSEcCtD
Eletriptan—Anxiety—Thalidomide—leprosy	0.000426	0.00309	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000424	0.00308	CcSEcCtD
Eletriptan—Discomfort—Thalidomide—leprosy	0.000422	0.00306	CcSEcCtD
Eletriptan—Dry mouth—Thalidomide—leprosy	0.000418	0.00303	CcSEcCtD
Eletriptan—Confusional state—Thalidomide—leprosy	0.000413	0.003	CcSEcCtD
Eletriptan—Oedema—Thalidomide—leprosy	0.00041	0.00297	CcSEcCtD
Eletriptan—Shock—Thalidomide—leprosy	0.000403	0.00292	CcSEcCtD
Eletriptan—Nervous system disorder—Thalidomide—leprosy	0.000402	0.00291	CcSEcCtD
Eletriptan—Tachycardia—Thalidomide—leprosy	0.0004	0.0029	CcSEcCtD
Eletriptan—Skin disorder—Thalidomide—leprosy	0.000398	0.00289	CcSEcCtD
Eletriptan—Hyperhidrosis—Thalidomide—leprosy	0.000396	0.00287	CcSEcCtD
Eletriptan—Anorexia—Thalidomide—leprosy	0.00039	0.00283	CcSEcCtD
Eletriptan—Hypotension—Thalidomide—leprosy	0.000383	0.00278	CcSEcCtD
Eletriptan—PTGS1—testis—leprosy	0.000381	0.00462	CbGeAlD
Eletriptan—PTGS1—nervous system—leprosy	0.000374	0.00454	CbGeAlD
Eletriptan—Musculoskeletal discomfort—Thalidomide—leprosy	0.000373	0.00271	CcSEcCtD
Eletriptan—Insomnia—Thalidomide—leprosy	0.00037	0.00269	CcSEcCtD
Eletriptan—Paraesthesia—Thalidomide—leprosy	0.000368	0.00267	CcSEcCtD
Eletriptan—Dyspnoea—Thalidomide—leprosy	0.000365	0.00265	CcSEcCtD
Eletriptan—Somnolence—Thalidomide—leprosy	0.000364	0.00264	CcSEcCtD
Eletriptan—Dyspepsia—Thalidomide—leprosy	0.000361	0.00261	CcSEcCtD
Eletriptan—Decreased appetite—Thalidomide—leprosy	0.000356	0.00258	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Thalidomide—leprosy	0.000354	0.00256	CcSEcCtD
Eletriptan—Fatigue—Thalidomide—leprosy	0.000353	0.00256	CcSEcCtD
Eletriptan—Pain—Thalidomide—leprosy	0.00035	0.00254	CcSEcCtD
Eletriptan—Constipation—Thalidomide—leprosy	0.00035	0.00254	CcSEcCtD
Eletriptan—Feeling abnormal—Thalidomide—leprosy	0.000338	0.00245	CcSEcCtD
Eletriptan—Gastrointestinal pain—Thalidomide—leprosy	0.000335	0.00243	CcSEcCtD
Eletriptan—Urticaria—Thalidomide—leprosy	0.000325	0.00236	CcSEcCtD
Eletriptan—Body temperature increased—Thalidomide—leprosy	0.000324	0.00235	CcSEcCtD
Eletriptan—Abdominal pain—Thalidomide—leprosy	0.000324	0.00235	CcSEcCtD
Eletriptan—CYP2D6—testis—leprosy	0.000313	0.0038	CbGeAlD
Eletriptan—CYP3A4—nervous system—leprosy	0.000312	0.00379	CbGeAlD
Eletriptan—CYP2D6—nervous system—leprosy	0.000307	0.00373	CbGeAlD
Eletriptan—Hypersensitivity—Thalidomide—leprosy	0.000302	0.00219	CcSEcCtD
Eletriptan—Asthenia—Thalidomide—leprosy	0.000294	0.00213	CcSEcCtD
Eletriptan—Pruritus—Thalidomide—leprosy	0.00029	0.0021	CcSEcCtD
Eletriptan—Diarrhoea—Thalidomide—leprosy	0.00028	0.00203	CcSEcCtD
Eletriptan—Dizziness—Thalidomide—leprosy	0.000271	0.00196	CcSEcCtD
Eletriptan—Vomiting—Thalidomide—leprosy	0.00026	0.00189	CcSEcCtD
Eletriptan—Rash—Thalidomide—leprosy	0.000258	0.00187	CcSEcCtD
Eletriptan—Dermatitis—Thalidomide—leprosy	0.000258	0.00187	CcSEcCtD
Eletriptan—Headache—Thalidomide—leprosy	0.000257	0.00186	CcSEcCtD
Eletriptan—Nausea—Thalidomide—leprosy	0.000243	0.00176	CcSEcCtD
Eletriptan—ABCB1—testis—leprosy	0.000225	0.00273	CbGeAlD
Eletriptan—ABCB1—nervous system—leprosy	0.000221	0.00268	CbGeAlD
